Rest of ArborGen acquired for $US167 million below carrying value.
Tim Hunter Thu, 06 Jul 2017
Timber industry investor Rubicon says it may take months to determine the fair value of its new subsidiary ArborGen, after buying out its joint venture partners at a significant discount.
On June 29 Rubicon said it had agreed to pay $US29 million ($39 million) for the 68.3% of US tree genetics
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).